Carnegie Investment Counsel

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1511506 PEPPER PIKE, OH

Position in IOVA

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$133,120

+$11,674 QoQ

Shares Held

32,000

-7.5% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#176

of 293 holders

Holding Since

Dec 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Carnegie Investment Counsel holds $232,130 across 2 Biotechnology names. IOVA ranks #1 (57.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	IOVA	Iovance Biotherapeutics, Inc. This page	32,000	$133,120
2	AVXL	Anavex Life Sciences Corp.	38,228	$99,010

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$133,120	32,000	-7.5%	Shares	Sole	2026-07-30
2026-03-31	$121,446	34,600	-3.9%	Shares	Sole	2026-05-01
2025-12-31	$98,280	36,000	-2.7%	Shares	Sole	2026-01-23
2025-09-30	$80,290	37,000	+19.4%	Shares	Sole	2025-10-16
2025-06-30	$53,320	31,000	+14.8%	Shares	Sole	2025-07-31
2024-12-31	$199,800	27,000	0.0%	Shares	Sole	2025-01-15
2024-09-30	$253,530	27,000	0.0%	Shares	Sole	2024-10-10
2024-06-30	$216,540	27,000	-1.5%	Shares	Sole	2024-07-22
2024-03-31	$406,068	27,400	0.0%	Shares	Sole	2024-05-06
2023-12-31	$222,762	27,400	+17.1%	Shares	Sole	2024-01-30
2023-09-30	$106,470	23,400	+88.7%	Shares	Sole	2023-10-11
2023-06-30	$87,296	12,400	-41.6%	Shares	Sole	2023-08-04
2021-09-30	$524,025	21,250	-12.4%	Shares	Sole	2021-10-08
2021-06-30	$630,985	24,250	+0.8%	Shares	Sole	2021-07-16
2021-03-31	$761,423	24,050	-7.7%	Shares	Sole	2021-04-12
2020-12-31	$1,208,720	26,050	—	Shares	Sole	2021-02-08
No filing history on record for this holder in this stock.